Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides.
Quick Facts
What This Study Found
CPPs can effectively deliver antidiabetic peptides like insulin and exendin-4 through the nasal route.
Key Numbers
How They Did This
The review discusses various methodologies for enhancing the nasal delivery of macromolecular therapeutics, focusing on CPPs.
Why This Research Matters
This research could lead to more effective treatments for diabetes and Alzheimer's disease by improving drug delivery methods. It highlights a non-invasive approach that could enhance patient compliance.
What This Study Doesn't Tell Us
As a review, it does not present original experimental data and may not cover all recent advancements in the field.
Trust & Context
- Original Title:
- Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides.
- Published In:
- Frontiers in pharmacology, 13, 1068495 (2022)
- Authors:
- Maeng, Jeehye, Lee, Kyunglim
- Database ID:
- RPEP-06343
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06343APA
Maeng, Jeehye; Lee, Kyunglim. (2022). Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides.. Frontiers in pharmacology, 13, 1068495. https://doi.org/10.3389/fphar.2022.1068495
MLA
Maeng, Jeehye, et al. "Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides.." Frontiers in pharmacology, 2022. https://doi.org/10.3389/fphar.2022.1068495
RethinkPeptides
RethinkPeptides Research Database. "Systemic and brain delivery of antidiabetic peptides through..." RPEP-06343. Retrieved from https://rethinkpeptides.com/research/maeng-2022-systemic-and-brain-delivery
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.